Год: 2004
Язык: Russian
Этот материал также есть на других языках: Английский Испанский
Формат: Документ
Also Available In: English, Spanish
This is not an official WFH translation. This resource has been translated with permission by a WFH National Member Organization (NMO), and is shared here with their kind permission. Translating organizations are encouraged to have translations reviewed by local experts, the WFH is not responsible for the translation or for any errors or changes to content from the original English edition. Patient organizations interested in translating a WFH resource must first obtain permission from the WFH, available here.
Treatment for bleeding in hemophilia involves replacement therapy of the missing coagulation factor, but adequate replacement therapy is not always available. This monograph describes conservative measures that decrease or control bleeding and help prevent future damage.
Всемирная федерация гемофилии пригласила представителей своих национальных членских организаций, национальных правительств, поставщиков медицинских услуг, партнеров из промышленности и других организаций
A summary of discussions held at the Eleventh WFH Global Forum on Research and Treatment Products for Bleeding Disorders which
This module was presented by Susan Cutter at the Virtual Workshop for Psychosocial Professionals in Europe on June 23, 2021.
Listen to this 2-hour webinar presented on April 22, 2021 to learn about global topics related to bleeding disorders. The
This illustrated schematic demonstrates the normal process of blood clotting, how it is diminished when a clotting factor is lacking,
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Polish Desmopressin (DDAVP) may
© 2025 World Federation of Hemophilia
